TY - BOOK ID - 138635777 TI - Innovative Radiopharmaceuticals in Oncology and Neurology AU - Michel Cherel AU - Jacques Barbet AU - Francoise Kraeber-Bodere AU - Denis Guilloteau PY - 2017 PB - Frontiers Media SA DB - UniCat KW - multimodality imaging KW - PET imaging KW - targeted radionuclide therapy KW - Radiopharmaceuticals KW - theranostic KW - Pretargeted radioimmunotherapy KW - personalized medicine UR - https://www.unicat.be/uniCat?func=search&query=sysid:138635777 AB - The aim of this Research Topic was to assemble a series of articles describing basic, preclinical and clinical research studies on radiopharmaceuticals and nuclear medicine. The articles were written by attendees of the third Nuclear Technologies for Health Symposium (NTHS, 10th-11th March 2015, Nantes, Frances) under the auspices of the IRON LabEx (Innovative Radiopharmaceuticals for Oncology and Neurology Laboratory of Excellence). This French network, gathering approximately 160 scientists from 12 academic research teams (Funded by “investissements d’Avenir”), fosters transdisciplinary projects between teams with expertise in chemistry, radiochemistry, radiopharmacy, formulation, biology, nuclear medicine and medical physics. The 12 articles within this resulting eBook present a series of comprehensive reviews and original research papers on multimodality imaging and targeted radionuclide therapy; illustrating the different facets of studies currently conducted in these domains. ER -